07/15/2021

Invitation for Bid: Purchase of Lyophilizer at IVI

INVITATION FOR BID [Purchase of Lyophilizer at IVI]   The International Vaccine Institute (IVI) now invites sealed proposals from interested parties for the supply of the following goods and/or services:   Ref. No: IVI-DVT/2021-0715 Deadline for proposal submission: 17:00 on July 28, 2021, KST(GMT + […]
07/15/2021

IVI welcomes Bangladesh as state party with ratification ceremony

  July 15, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years of vaccine research and capacity-building initiatives with partners in Bangladesh […]
07/20/2021

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding […]
07/26/2021

THECA consortium begins Vi-TT typhoid conjugate vaccine phase IV effectiveness study in Ghana

July 26, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing typhoid infection in children in Asante Akim, Ghana […]